Psiquiatria
Novas ferramentas da OMS para a inclusão de pessoas com demência na sociedade.
11 Ago, 2021 | 10:39hNew WHO toolkit promotes inclusion of people with dementia in society – World Health Organization
Ver Diretriz: Towards a dementia inclusive society: WHO toolkit for dementia-friendly initiatives (DFIs) – World Health Organization
Comentário no Twitter (fio – clique para saber mais)
🆕 toolkit to promote a #dementia-inclusive society launched. It will helps countries raise public awareness and understanding of dementia to support people living with dementia to remain in, and be a significant part of, their communities.
👉 https://t.co/blpDQHUSWM pic.twitter.com/D5MIM5jdlr
— World Health Organization (WHO) (@WHO) August 10, 2021
M-A | Problemas de saúde mental em crianças e jovens dobraram durante a COVID-19.
10 Ago, 2021 | 12:49hComentário: Child and youth mental health problems have doubled during COVID-19 – The Conversation
Estudo original: Global Prevalence of Depressive and Anxiety Symptoms in Children and Adolescents During COVID-19: A Meta-analysis – JAMA Pediatrics
Editorial: Addressing the Global Crisis of Child and Adolescent Mental Health – JAMA Pediatrics
Conteúdos relacionados:
More data on the harmful effects of the COVID-19 pandemic on the mental health of adolescents.
COVID has caused ‘mass trauma,’ worsening mental health globally.
COVID’s mental-health toll: how scientists are tracking a surge in depression
WHO: COVID-19 disrupting mental health services in most countries
Comentário no Twitter (fio – clique para saber mais)
Many are rightfully sounding the alarm to a youth #mentalhealth crisis. Our meta-analysis of 29 studies w >80,000 youth worldwide in @JAMAPediatrics, shows 1 in 4 youth had elevated depression or anxiety during #COVID19. A thread 🧵 https://t.co/etIdZTHnme
— Dr. Sheri Madigan (she/her) (@sherimadigan) August 9, 2021
Perspectiva | Experiência de fora da Academia: redução de antidepressivos.
9 Ago, 2021 | 11:06hExpertise from outside the Academy: tapering off antidepressants – The Mental Elf
Conteúdos relacionados:
A method for tapering antipsychotic treatment that may minimize the risk of relapse
Systematic Review: Managing Antidepressant Discontinuation
Randomized controlled trial: preventive cognitive therapy for prevention of depressive recurrence
Diretriz AAP sobre apoio às necessidades de saúde emocional e comportamental de crianças, adolescentes e famílias durante a pandemia de COVID-19.
4 Ago, 2021 | 12:38hDiretriz sobre Cannabis e analgesia com canabinoides – “Em razão da falta de evidências clínicas de alta qualidade, atualmente o IASP não endossa o uso generalizado de cannabis e canabinoides para alívio da dor.”
4 Ago, 2021 | 12:24hVer também:
Comentários:
More evidence needed to back cannabis as pain treatment, says review – Imperial College London
Medicinal cannabis to manage chronic pain? We don’t have evidence it works – The Conversation
Conteúdos relacionados:
NICE Guideline: Cannabis-Based Medicinal Products
Short Review: Drug Interactions with Cannabinoids
Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain
Estudo randomizado | Tratamento de rotina com fluoxetina não reduz a incidência de depressão após AVC.
4 Ago, 2021 | 12:14hDepression Outcomes Among Patients Treated With Fluoxetine for Stroke Recovery: The AFFINITY Randomized Clinical Trial – JAMA Neurology (free for a limited period)
Editorial: Poststroke Selective Serotonin Reuptake Inhibitors—Do They Work for Anything? (gratuito por tempo limitado)
Conteúdos relacionados:
[Abstract Only] Randomized trial: Fluoxetine does not improve functional recovery after acute stroke
Randomized Trial: Effects of Fluoxetine on Functional Outcomes After Acute Stroke
Estudo | Pacientes recuperados da COVID-19 podem ter sintomas cognitivos persistentes.
2 Ago, 2021 | 18:25hCognitive deficits in people who have recovered from COVID-19 – EClinicalMedicine
Comentário no Twitter (fio – clique para saber mais)
We assessed thousands and saw clear evidence of cognitive deficits in people who have recovered from COVID-19. Took a while to appease peer reviewers, but the results stand. Brilliantly led by @HampshireHub. @Amy2Jolly @JoeBarnby @srchamb @neurohellyer https://t.co/AnbhanixRk
— mitul mehta (@mehta_mitul72) July 23, 2021
Problemas de memória autorrelatados 8 meses após a COVID-19.
2 Ago, 2021 | 18:22hSelf-reported Memory Problems 8 Months After COVID-19 Infection – JAMA Network Open
Comentário: Post-acute Sequelae of SARS-CoV-2 Infection and Subjective Memory Problems – JAMA Network Open
Comentário no Twitter (fio – clique para saber mais)
Concerning data out now in @JAMANetworkOpen about cognitive symptoms in #LongCovid among *non-hospitalized* adults.
Researchers in Norway invited 35,000 adults at the time of #coronavirus testing as well as a 20,000 person untested random sample to a prospective cohort.
(1/6) pic.twitter.com/AaU5rrwaPw
— F. Perry Wilson, MD MSCE (@fperrywilson) July 29, 2021
Revisão sistemática e metanálise de depressão, ansiedade e ideação suicida entre doutorandos.
2 Ago, 2021 | 16:42h
Comentários no Twitter
A study in @SciReports concludes that depression and anxiety are highly prevalent among PhD students and programs to monitor and promote mental health are urgently needed. https://t.co/zTWxGC4Rs0 pic.twitter.com/tINXMmeJWj
— Nature Portfolio (@NaturePortfolio) July 27, 2021
*New* meta-analysis of >15K PhD students finds that 24% have clinical symptoms of depression & 17% of anxiety.
As a baseline: The prevalence of major depression among young adults in the US is ~13% & anxiety disorder is 4%.
Ht @wormmaps https://t.co/QPxHj0tgTc
— Amy Maxmen, PhD (@amymaxmen) July 13, 2021
M-A | Pacientes psiquiátricos têm risco aumentado de hospitalização e morte por COVID-19.
26 Jul, 2021 | 10:20hComunicado de imprensa: Psychiatric patients at increased risk of COVID-19 hospitalization and mortality – European College of Neuropsychopharmacology